Glycomics Market Size, Trends and Insights By Product Type (Reagents, Enzymes, Kits, Equipment), By Application (Diagnostics, Drug Discovery & Development, Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, CROs, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Mueller Water Products Inc.
- Viking Johnson
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Shimadzu Corporation
- Merck KGaA
- Others
Reports Description
Global Glycomics Market was valued at USD 1.8 Billion in 2024 and is expected to reach USD 5.2 Billion by 2033, at a CAGR of 13.6% during the forecast period 2024 – 2033.
Glycomics is an area of research that studies the structure, function, and biology of carbohydrates (sugars) in living systems. It includes an in-depth analysis of complex sugars (also known as glycans) and their interactions with other molecules which include proteins, lipids, and nucleic acids.
Glycomics Market: Growth Factors
Technological advancements in glycomics instruments
Technological breakthroughs in glycomics devices are moving the glycomics market forward by allowing scientists to more accurately investigate the complex structures and functions of glycans than ever before. These advances have transformed glycomics research by increasing the speed, accuracy, and depth of glycan analysis.
One significant innovation is the introduction of high-throughput glycomics equipment, which automates and speeds glycan analysis. These tools can analyse vast quantities of samples in a fraction of the time it used to take, allowing researchers to explore glycan structures and interactions at previously unachievable scales.
Furthermore, advances in mass spectrometry and chromatography technology have increased the accuracy and precision of glycan analysis, allowing researchers to identify and characterize glycans more precisely.
Moreover, advances in software algorithms and bioinformatics tools have made it easier to evaluate complicated glycomics data, allowing researchers to draw useful conclusions from enormous datasets.
The combination of modern technology and sophisticated data analysis techniques has increased the potential of glycomics research and opened up new paths for studying the function of glycans in health and illness.
Ultimately, technological improvements in glycomics instruments are driving development in the field and propelling the glycomics market expansion by allowing the researcher to discover the complex biology of glycans and their influence on human health and illness.
Rising focus on glycobiology research studies
The growing interest in glycobiology research has accelerated the glycomics industry, boosting innovation and expansion. Glycobiology, the study of carbohydrates and their biological functions has grown in popularity owing to its relevance to a variety of physiological processes, disease mechanisms, and therapeutic advancements.
As researchers learn more about the complex roles of glycans in cellular communication, immunological response, and disease development, there is an increasing demand for better techniques and technology for analysing and understanding glycan structures and functions.
This increased emphasis on glycobiology research investigations has fuelled the growth of the glycomics market by creating a need for specialized analytical tools, software, and services designed for glycan analysis.
Entrepreneurs in the glycomics sector are creating novel solutions like as mass spectrometry, chromatography, glycan arrays, and bioinformatics platforms to satisfy the changing demands of academics and physicians.
Furthermore, cooperation between academia, industry, and healthcare institutions is propelling translational research forward, resulting in the development of glycan-based biomarkers, diagnostics, and therapies for a variety of illnesses such as cancer, infectious diseases, and autoimmune disorders.
The integration of scientific knowledge, technological breakthroughs, and clinical applications emphasizes the importance of glycobiology research in influencing the future of personalized medicine and healthcare. Thus, the increased emphasis on glycobiology research investigations acts as a driver for the glycomics market’s development and progress, opening up new possibilities for biomedical innovation and discovery.
Glycomics Market: Restraints
High cost of research
The high expense of research is a considerable barrier to entrance and expansion in the glycomics business. Glycomics, the study of the structure and function of carbohydrates (glycans) in biological systems, necessitates complex equipment, specialised reagents, and professional individuals to perform research properly.
These resources entail significant expenditures, including equipment purchase and maintenance, reagent procurement, and professional researcher labour. Furthermore, glycomics research frequently employs complicated techniques such as mass spectrometry, chromatography, and glycan microarray analysis, which adds to the total study cost.
The high expense of research restricts glycomics studies to university institutions, research laboratories, and biotechnology businesses with substantial financial resources, preventing smaller organizations and researchers from joining the market or expanding their research efforts.
As a result, lowering the cost of research through technical breakthroughs, cooperation, and financing efforts is critical for encouraging innovation and increasing the glycomics industry.
Glycomics Market: Opportunities
Demand for personalized healthcare and precision diagnostic solutions
The growing desire for personalized healthcare and precision medicine-driven diagnostic solutions is a major driver of the glycomics industry. Glycomics, the study of the structure and function of complex carbohydrates (glycans) in biological systems, is critical for understanding disease processes and creating tailored treatments.
As personalized medicine seeks to customize medical therapy to individual patients based on genetic, environmental, and lifestyle variables, glycomics provides important insights into the complex glycan structures that govern cellular functions and disease pathways.
Glycan changes have been associated with several illnesses, including cancer, autoimmune disorders, and infectious diseases. Precision medicine techniques use glycomics to uncover disease-specific glycan biomarkers that may be used for early identification, prognosis, and therapy response monitoring.
Moreover, advances in glycomics technologies like as mass spectrometry, chromatography, and glycosyl microarray analysis have enabled high-throughput glycan profiling with increased sensitivity and accuracy. This enables the detection of small glycan changes associated with various disease states, opening the path for the creation of new diagnostic tests and therapeutic therapies.
Glycomics Market: Segmentation Analysis
Global Glycomics market is segmented by product type, application, end user and region. Based on product type, the market is classified into reagents, enzymes, kits, and equipment. Enzymes dominated the market in 2023 with a market share of 30.7% and are expected to keep their dominance during the forecast period 2024-2033.
Enzymes play an important role in driving the glycomics market because of their capacity to catalyse biochemical events required in the study of complex carbohydrates, or glycans. Glycomics, the study of glycan structure and function, is primarily reliant on enzymatic methods for analysis, modification, and synthesis.
Glycosidases, glycosyltransferases, and hydrolases are enzymes that use great specificity and efficiency to cleave, alter, and synthesize glycans. These enzymes allow scientists to comprehend the complex structures of glycans, understand their functions in biological processes, and create glycan-based diagnostics, treatments, and biotechnological applications.
Moreover, advances in enzyme engineering and glycoengineering approaches are spurring innovation in glycomics research, broadening the area of glycan analysis and modification. In conclusion, enzymes serve as vital instruments to advance scientific knowledge of glycans and drive growth in the glycomics market.
Based on application, the market is classified into diagnostics, drug discovery & development, and others. Drug discovery & development dominated the market in 2023 with a market share of 42.5% and is expected to keep its dominance during the forecast period 2024-2033.
Drug discovery and development are critical drivers of the glycomics market because they increase demand for glycomics research and technology. Glycomics, the study of complex carbohydrate structures known as glycans, has enormous potential in drug discovery due to its critical role in different biological processes and disease pathways.
Identifying glycan activities and interactions can lead to the identification of new pharmacological targets and therapeutic agents for cancer, infectious illnesses, and autoimmune disorders. Furthermore, glycomics tools involving mass spectrometry, chromatography, and glycan array analysis allow researchers to analyse and modify glycans more precisely, which speeds up the drug development process.
Based on application, the market is classified into biopharmaceutical companies, academic & research institutes, CROs, and others. Academic & research institutes dominated the market in 2023 with a market share of 38.8% and are expected to keep their dominance during the forecast period 2024-2033.
Academic and research institutes contribute significantly to the glycomics industry by conducting basic research, developing technology, and disseminating information. These universities perform cutting-edge research on the composition, functioning, and role of carbohydrates (glycans) in biological systems, resulting in new insights into glycan-related illnesses, diagnostics, and therapies.
Academic investigators pave the path for novel glycomics technologies and applications by deciphering the complicated interactions between glycans and proteins, lipids, and nucleic acids. Moreover, academic institutes act as multidisciplinary cooperation centers, bringing together professionals from a variety of domains such as biology, chemistry, bioinformatics, and medicine to further glycomics research.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 1.8 Billion |
| Projected Market Size in 2033 | USD 5.2 Billion |
| Market Size in 2023 | USD 1.6 Billion |
| CAGR Growth Rate | 13.6% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product Type, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Glycomics Market: Regional Analysis
By region, Glycomics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. North America dominated the global Glycomics market in 2023 with a market share of 39.1% and is expected to keep its dominance during the forecast period 2024-2033.
North America leads the glycomics market through several major aspects. For starters, the region has a strong healthcare infrastructure and large expenditures in R&D, which encourages innovation in glycomics technology.
Furthermore, North America is home to a huge number of pharmaceutical and biotechnology businesses that are increasingly using glycomics in drug discovery and development. Furthermore, universities and research institutes in North America are at the forefront of glycomics research, undertaking ground-breaking studies and collaborating to move the industry ahead.
Furthermore, government initiatives and financing assistance have accelerated the expansion of the glycomics industry in North America.
Glycomics Market: Recent Developments
- In March 2024, Bruker Corporation reported advancements in immunopeptidomics, glycoproteomics, and other 4D proteomics processes enabled by Collision Cross Section (CCS).
- In September 2021, researchers at the University of California San Diego developed a tool for analyzing glycomics information utilizing explainable Artificial Intelligence (AI) systems and other machine learning methodologies.
- In January 2024, Vector Laboratories signed an agreement with Navinci Diagnostics, This collaboration aims to produce cutting-edge biomarker discovery techniques that will recognize particular protein glycosylation in tissue samples for the first time.
List of the prominent players in the Glycomics Market:
- Mueller Water Products Inc.
- Viking Johnson
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Shimadzu Corporation
- Merck KGaA
- Waters Corporation
- New England Biolabs Inc.
- Bruker Corporation
- Danaher Corporation
- RayBiotech Inc.
- Takara Bio Inc.
- GlycoPro Technologies Pvt. Ltd.
- ProZyme Inc.
- Creative Diagnostics
- Ludger Ltd.
- Z Biotech LLC
- Bio-Techne Corporation
- S-BIO
- Chemily Glycoscience
- R&D Systems Inc.
- Sumitomo Bakelite Co. Ltd.
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Glycomics Market is segmented as follows:
By Product Type
- Reagents
- Enzymes
- Kits
- Equipment
By Application
- Diagnostics
- Drug Discovery & Development
- Others
By End User
- Biopharmaceutical Companies
- Academic & Research Institutes
- CROs
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Glycomics Market, (2024 – 2033) (USD Billion)
- 2.2 Global Glycomics Market: snapshot
- Chapter 3. Global Glycomics Market – Industry Analysis
- 3.1 Glycomics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Technological advancements in glycomics instruments
- 3.2.2 Rising focus on glycobiology research studies
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Glycomics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Glycomics Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Glycomics Market – Product Type Analysis
- 5.1 Global Glycomics Market Overview: By Product Type
- 5.1.1 Global Glycomics Market Share, By Product Type, 2023 and 2033
- 5.2 Reagents
- 5.2.1 Global Glycomics Market by Reagents, 2024 – 2033 (USD Billion)
- 5.3 Enzymes
- 5.3.1 Global Glycomics Market by Enzymes, 2024 – 2033 (USD Billion)
- 5.4 Kits
- 5.4.1 Global Glycomics Market by Kits, 2024 – 2033 (USD Billion)
- 5.5 Equipment
- 5.5.1 Global Glycomics Market by Equipment, 2024 – 2033 (USD Billion)
- 5.1 Global Glycomics Market Overview: By Product Type
- Chapter 6. Global Glycomics Market – Application Analysis
- 6.1 Global Glycomics Market Overview: By Application
- 6.1.1 Global Glycomics Market Share, By Application, 2023 and 2033
- 6.2 Diagnostics
- 6.2.1 Global Glycomics Market by Diagnostics, 2024 – 2033 (USD Billion)
- 6.3 Drug Discovery & Development
- 6.3.1 Global Glycomics Market by Drug Discovery & Development, 2024 – 2033 (USD Billion)
- 6.4 Others
- 6.4.1 Global Glycomics Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global Glycomics Market Overview: By Application
- Chapter 7. Global Glycomics Market – End User Analysis
- 7.1 Global Glycomics Market Overview: By End User
- 7.1.1 Global Glycomics Market Share, By End User, 2023 and 2033
- 7.2 Biopharmaceutical Companies
- 7.2.1 Global Glycomics Market by Biopharmaceutical Companies, 2024 – 2033 (USD Billion)
- 7.3 Academic & Research Institutes
- 7.3.1 Global Glycomics Market by Academic & Research Institutes, 2024 – 2033 (USD Billion)
- 7.4 CROs
- 7.4.1 Global Glycomics Market by CROs, 2024 – 2033 (USD Billion)
- 7.5 Others
- 7.5.1 Global Glycomics Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global Glycomics Market Overview: By End User
- Chapter 8. Glycomics Market – Regional Analysis
- 8.1 Global Glycomics Market Regional Overview
- 8.2 Global Glycomics Market Share, by Region, 2023 & 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Glycomics Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Glycomics Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Glycomics Market, 2024 – 2033 (USD Billion)
- 8.4 North America Glycomics Market, by Product Type, 2024 – 2033
- 8.4.1 North America Glycomics Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.5 North America Glycomics Market, by Application, 2024 – 2033
- 8.5.1 North America Glycomics Market, by Application, 2024 – 2033 (USD Billion)
- 8.6 North America Glycomics Market, by End User, 2024 – 2033
- 8.6.1 North America Glycomics Market, by End User, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Glycomics Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Glycomics Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Glycomics Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Glycomics Market, by Product Type, 2024 – 2033
- 8.8.1 Europe Glycomics Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.9 Europe Glycomics Market, by Application, 2024 – 2033
- 8.9.1 Europe Glycomics Market, by Application, 2024 – 2033 (USD Billion)
- 8.10 Europe Glycomics Market, by End User, 2024 – 2033
- 8.10.1 Europe Glycomics Market, by End User, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Glycomics Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Glycomics Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Glycomics Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Glycomics Market, by Product Type, 2024 – 2033
- 8.12.1 Asia Pacific Glycomics Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Glycomics Market, by Application, 2024 – 2033
- 8.13.1 Asia Pacific Glycomics Market, by Application, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Glycomics Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Glycomics Market, by End User, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Glycomics Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Glycomics Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Glycomics Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Glycomics Market, by Product Type, 2024 – 2033
- 8.16.1 Latin America Glycomics Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.17 Latin America Glycomics Market, by Application, 2024 – 2033
- 8.17.1 Latin America Glycomics Market, by Application, 2024 – 2033 (USD Billion)
- 8.18 Latin America Glycomics Market, by End User, 2024 – 2033
- 8.18.1 Latin America Glycomics Market, by End User, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Glycomics Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Glycomics Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Glycomics Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Glycomics Market, by Product Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa Glycomics Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Glycomics Market, by Application, 2024 – 2033
- 8.21.1 The Middle-East and Africa Glycomics Market, by Application, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Glycomics Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Glycomics Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Mueller Water Products Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Viking Johnson
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Thermo Fisher Scientific Inc.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Agilent Technologies Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Shimadzu Corporation
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Merck KGaA
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Waters Corporation
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 New England Biolabs Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Bruker Corporation
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Danaher Corporation
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 RayBiotech Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Takara Bio Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 GlycoPro Technologies Pvt. Ltd.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 ProZyme Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Creative Diagnostics
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Ludger Ltd.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Z Biotech LLC
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Bio-Techne Corporation
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 S-BIO
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Chemily Glycoscience
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 R&D Systems Inc.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.22 Sumitomo Bakelite Co. Ltd.
- 9.22.1 Overview
- 9.22.2 Financials
- 9.22.3 Product Portfolio
- 9.22.4 Business Strategy
- 9.22.5 Recent Developments
- 9.23 Others.
- 9.23.1 Overview
- 9.23.2 Financials
- 9.23.3 Product Portfolio
- 9.23.4 Business Strategy
- 9.23.5 Recent Developments
- 9.1 Mueller Water Products Inc.
List Of Figures
Figures No 1 to 27
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Mueller Water Products Inc.
- Viking Johnson
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Shimadzu Corporation
- Merck KGaA
- Waters Corporation
- New England Biolabs Inc.
- Bruker Corporation
- Danaher Corporation
- RayBiotech Inc.
- Takara Bio Inc.
- GlycoPro Technologies Pvt. Ltd.
- ProZyme Inc.
- Creative Diagnostics
- Ludger Ltd.
- Z Biotech LLC
- Bio-Techne Corporation
- S-BIO
- Chemily Glycoscience
- R&D Systems Inc.
- Sumitomo Bakelite Co. Ltd.
- Others
FAQs
The major driver for the Glycomics market is technological advancements in glycomics instruments and rising focus on glycobiology research studies.
The “Diagnostics” had the largest share in the global market for Glycomics.
The “Reagents” category dominated the market in 2023.
The key players in the market are Mueller Water Products Inc., Viking Johnson, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Shimadzu Corporation, Merck KGaA, Waters Corporation, New England Biolabs Inc., Bruker Corporation, Danaher Corporation, RayBiotech Inc., Takara Bio Inc., GlycoPro Technologies Pvt. Ltd., ProZyme Inc., Creative Diagnostics, Ludger Ltd., Z Biotech LLC, Bio-Techne Corporation, S-BIO, Chemily Glycoscience, R&D Systems Inc., Sumitomo Bakelite Co. Ltd., Others.
“North America” had the largest share in the Glycomics Market.
The global market is projected to grow at a CAGR of 13.6% during the forecast period, 2024-2033.
The Glycomics Market size was valued at USD 1.8 Billion in 2024.